TGF-β signaling and the role of inhibitory smads in non-small cell lung cancer

Hyo Sung Jeon, Jin Jen

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The signaling pathway mediated by transforming growth factor-β (TGF-β) participates in various biologic processes, including cell growth, differentiation, angiogenesis, apoptosis, and extracellular matrix remodeling. In the context of cancer, TGF-β signaling can inhibit tumor growth in early-stage tumors. However, in late-stage tumors, the very same pathway promotes tumor invasiveness and metastasis. This paradoxical effect is mediated through similar to mothers against decapentaplegic or Smad protein dependent and independent mechanisms and provides an opportunity for targeted cancer therapy. This review summarizes the molecular process of TGF-β signaling and the changes in inhibitory Smads that contribute to lung cancer progression. We also present current approaches for rational therapies that target the TGF-β signaling pathway in cancer.

Original languageEnglish (US)
Pages (from-to)417-419
Number of pages3
JournalJournal of Thoracic Oncology
Volume5
Issue number4
DOIs
StatePublished - Apr 2010

Fingerprint

Transforming Growth Factors
Non-Small Cell Lung Carcinoma
Neoplasms
Smad Proteins
Extracellular Matrix
Cell Differentiation
Lung Neoplasms
Apoptosis
Neoplasm Metastasis
Therapeutics
Growth

Keywords

  • Non-small cell lung cancer survival
  • Smads
  • Target-based therapy
  • TGF-β signaling

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

TGF-β signaling and the role of inhibitory smads in non-small cell lung cancer. / Jeon, Hyo Sung; Jen, Jin.

In: Journal of Thoracic Oncology, Vol. 5, No. 4, 04.2010, p. 417-419.

Research output: Contribution to journalArticle

@article{9a34abb2aff643c6b097447cd5577832,
title = "TGF-β signaling and the role of inhibitory smads in non-small cell lung cancer",
abstract = "The signaling pathway mediated by transforming growth factor-β (TGF-β) participates in various biologic processes, including cell growth, differentiation, angiogenesis, apoptosis, and extracellular matrix remodeling. In the context of cancer, TGF-β signaling can inhibit tumor growth in early-stage tumors. However, in late-stage tumors, the very same pathway promotes tumor invasiveness and metastasis. This paradoxical effect is mediated through similar to mothers against decapentaplegic or Smad protein dependent and independent mechanisms and provides an opportunity for targeted cancer therapy. This review summarizes the molecular process of TGF-β signaling and the changes in inhibitory Smads that contribute to lung cancer progression. We also present current approaches for rational therapies that target the TGF-β signaling pathway in cancer.",
keywords = "Non-small cell lung cancer survival, Smads, Target-based therapy, TGF-β signaling",
author = "Jeon, {Hyo Sung} and Jin Jen",
year = "2010",
month = "4",
doi = "10.1097/JTO.0b013e3181ce3afd",
language = "English (US)",
volume = "5",
pages = "417--419",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "4",

}

TY - JOUR

T1 - TGF-β signaling and the role of inhibitory smads in non-small cell lung cancer

AU - Jeon, Hyo Sung

AU - Jen, Jin

PY - 2010/4

Y1 - 2010/4

N2 - The signaling pathway mediated by transforming growth factor-β (TGF-β) participates in various biologic processes, including cell growth, differentiation, angiogenesis, apoptosis, and extracellular matrix remodeling. In the context of cancer, TGF-β signaling can inhibit tumor growth in early-stage tumors. However, in late-stage tumors, the very same pathway promotes tumor invasiveness and metastasis. This paradoxical effect is mediated through similar to mothers against decapentaplegic or Smad protein dependent and independent mechanisms and provides an opportunity for targeted cancer therapy. This review summarizes the molecular process of TGF-β signaling and the changes in inhibitory Smads that contribute to lung cancer progression. We also present current approaches for rational therapies that target the TGF-β signaling pathway in cancer.

AB - The signaling pathway mediated by transforming growth factor-β (TGF-β) participates in various biologic processes, including cell growth, differentiation, angiogenesis, apoptosis, and extracellular matrix remodeling. In the context of cancer, TGF-β signaling can inhibit tumor growth in early-stage tumors. However, in late-stage tumors, the very same pathway promotes tumor invasiveness and metastasis. This paradoxical effect is mediated through similar to mothers against decapentaplegic or Smad protein dependent and independent mechanisms and provides an opportunity for targeted cancer therapy. This review summarizes the molecular process of TGF-β signaling and the changes in inhibitory Smads that contribute to lung cancer progression. We also present current approaches for rational therapies that target the TGF-β signaling pathway in cancer.

KW - Non-small cell lung cancer survival

KW - Smads

KW - Target-based therapy

KW - TGF-β signaling

UR - http://www.scopus.com/inward/record.url?scp=77950977675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950977675&partnerID=8YFLogxK

U2 - 10.1097/JTO.0b013e3181ce3afd

DO - 10.1097/JTO.0b013e3181ce3afd

M3 - Article

C2 - 20107423

AN - SCOPUS:77950977675

VL - 5

SP - 417

EP - 419

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 4

ER -